Cite
HARVARD Citation
D'sa, F. et al. (2022). Use of histamine‐2 receptor antagonists and risk of inflammatory bowel diseases: A systematic review and meta‐analysis of observational studies. Journal of clinical pharmacy and therapeutics. pp. 1103-1111. [Online].